FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1750654101> ?p ?o ?g. }

• W1750654101 endingPage "1759" @default.
• W1750654101 startingPage "1751" @default.
• W1750654101 abstract "Fasiglifam (TAK-875), a selective G-protein-coupled receptor 40 agonist, was developed for the treatment of type 2 diabetes mellitus; however, its development was terminated in phase III clinical trials because of liver safety concerns. Our preliminary study indicated that intravenous administration of 100 mg/kg of TAK-875 increased the serum total bile acid concentration by 3 to 4 times and total bilirubin levels by 1.5 to 2.6 times in rats. In the present study, we examined the inhibitory effects of TAK-875 on hepatobiliary transporters to explore the mechanisms underlying its hepatotoxicity. TAK-875 decreased the biliary excretion index and the in vitro biliary clearance of d₈-taurocholic acid in sandwich-cultured rat hepatocytes, suggesting that TAK-875 impaired biliary excretion of bile acids, possibly by inhibiting bile salt export pump (Bsep). TAK-875 inhibited the efflux transporter multidrug resistance-associated protein 2 (Mrp2) in rat hepatocytes using 5 (and 6)-carboxy-2',7'-dichlorofluorescein as a substrate. Inhibition of MRP2 was further confirmed by reduced transport of vinblastine in Madin-Darby canine kidney cells overexpressing MRP2 with IC₅₀ values of 2.41 μM. TAK-875 also inhibited the major bile acid uptake transporter Na(+)/taurocholate cotransporting polypeptide (Ntcp), which transports d₈-taurocholic acid into rat hepatocytes, with an IC₅₀ value of 10.9 μM. TAK-875 significantly inhibited atorvastatin uptake in organic anion transporter protein (OATP) 1B1 and OATP1B3 cells with IC₅₀ values of 2.28 and 3.98 μM, respectively. These results indicate that TAK-875 inhibited the efflux transporter MRP2/Mrp2 and uptake transporters Ntcp and OATP/Oatp, which may affect bile acid and bilirubin homeostasis, resulting in hyperbilirubinemia and cholestatic hepatotoxicity." @default.
• W1750654101 created "2016-06-24" @default.
• W1750654101 creator A5001219472 @default.
• W1750654101 creator A5037105069 @default.
• W1750654101 creator A5060739855 @default.
• W1750654101 creator A5070602110 @default.
• W1750654101 creator A5088334971 @default.
• W1750654101 date "2015-08-14" @default.
• W1750654101 modified "2023-09-23" @default.
• W1750654101 title "Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury" @default.
• W1750654101 cites W1808672184 @default.
• W1750654101 cites W1984345984 @default.
• W1750654101 cites W1998116569 @default.
• W1750654101 cites W2002121467 @default.
• W1750654101 cites W2002176535 @default.
• W1750654101 cites W2014051119 @default.
• W1750654101 cites W2019532583 @default.
• W1750654101 cites W2021513482 @default.
• W1750654101 cites W2022730545 @default.
• W1750654101 cites W2025703258 @default.
• W1750654101 cites W2028890879 @default.
• W1750654101 cites W2031580730 @default.
• W1750654101 cites W2031896095 @default.
• W1750654101 cites W2034972283 @default.
• W1750654101 cites W2035330368 @default.
• W1750654101 cites W2040411965 @default.
• W1750654101 cites W2045039026 @default.
• W1750654101 cites W2051009834 @default.
• W1750654101 cites W2054951377 @default.
• W1750654101 cites W2069003463 @default.
• W1750654101 cites W2071101614 @default.
• W1750654101 cites W2071450296 @default.
• W1750654101 cites W2073730215 @default.
• W1750654101 cites W2078524075 @default.
• W1750654101 cites W2085134666 @default.
• W1750654101 cites W2093974511 @default.
• W1750654101 cites W2108571956 @default.
• W1750654101 cites W2128874766 @default.
• W1750654101 cites W2133074258 @default.
• W1750654101 cites W2147024197 @default.
• W1750654101 cites W2148917087 @default.
• W1750654101 cites W2149112832 @default.
• W1750654101 cites W2163841301 @default.
• W1750654101 cites W2165423709 @default.
• W1750654101 cites W2171636541 @default.
• W1750654101 cites W2302091022 @default.
• W1750654101 cites W2316475322 @default.
• W1750654101 cites W4231510412 @default.
• W1750654101 doi "https://doi.org/10.1124/dmd.115.064121" @default.
• W1750654101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26276582" @default.
• W1750654101 hasPublicationYear "2015" @default.
• W1750654101 type Work @default.
• W1750654101 sameAs 1750654101 @default.
• W1750654101 citedByCount "74" @default.
• W1750654101 countsByYear W17506541012015 @default.
• W1750654101 countsByYear W17506541012016 @default.
• W1750654101 countsByYear W17506541012017 @default.
• W1750654101 countsByYear W17506541012018 @default.
• W1750654101 countsByYear W17506541012019 @default.
• W1750654101 countsByYear W17506541012020 @default.
• W1750654101 countsByYear W17506541012021 @default.
• W1750654101 countsByYear W17506541012022 @default.
• W1750654101 countsByYear W17506541012023 @default.
• W1750654101 crossrefType "journal-article" @default.
• W1750654101 hasAuthorship W1750654101A5001219472 @default.
• W1750654101 hasAuthorship W1750654101A5037105069 @default.
• W1750654101 hasAuthorship W1750654101A5060739855 @default.
• W1750654101 hasAuthorship W1750654101A5070602110 @default.
• W1750654101 hasAuthorship W1750654101A5088334971 @default.
• W1750654101 hasBestOaLocation W17506541011 @default.
• W1750654101 hasConcept C104317684 @default.
• W1750654101 hasConcept C123584848 @default.
• W1750654101 hasConcept C126322002 @default.
• W1750654101 hasConcept C134018914 @default.
• W1750654101 hasConcept C149011108 @default.
• W1750654101 hasConcept C185592680 @default.
• W1750654101 hasConcept C200082930 @default.
• W1750654101 hasConcept C2776678969 @default.
• W1750654101 hasConcept C2779399885 @default.
• W1750654101 hasConcept C2780480987 @default.
• W1750654101 hasConcept C2910800957 @default.
• W1750654101 hasConcept C36201501 @default.
• W1750654101 hasConcept C44312359 @default.
• W1750654101 hasConcept C55493867 @default.
• W1750654101 hasConcept C71924100 @default.
• W1750654101 hasConcept C86803240 @default.
• W1750654101 hasConcept C98274493 @default.
• W1750654101 hasConceptScore W1750654101C104317684 @default.
• W1750654101 hasConceptScore W1750654101C123584848 @default.
• W1750654101 hasConceptScore W1750654101C126322002 @default.
• W1750654101 hasConceptScore W1750654101C134018914 @default.
• W1750654101 hasConceptScore W1750654101C149011108 @default.
• W1750654101 hasConceptScore W1750654101C185592680 @default.
• W1750654101 hasConceptScore W1750654101C200082930 @default.
• W1750654101 hasConceptScore W1750654101C2776678969 @default.
• W1750654101 hasConceptScore W1750654101C2779399885 @default.
• W1750654101 hasConceptScore W1750654101C2780480987 @default.
• W1750654101 hasConceptScore W1750654101C2910800957 @default.

• next